Excited to present the latest validation data (386 consecutive patients) for our novel pressure-regulated deployment strategy in Sapien 3 BE-TAVs. #ESCCongress later today - Station 4 15:15!
Spoiler alert: the results are excellent ✅
@escardio@thecsanz
https://t.co/sCnaRbeihk
Wonderful discussion about the best practice and evidence (or lack of thereof) for coronary assessment and revascularisation in HFrEF patients without clear angina #ESC2023
@PlayfordDavid on the timing of intervention in AS. Data from NEDA @AfikDSnir work on mortality outcomes in LFGAS. As physiologists we have to do everything we can to provide all the data, think small , thick LV , SVi, calculate fow rate ! Bring out that pedof probe ! #CSANZ2023
Brilliant study illustrating the role of pressure regulated (vs. volume regulated) valve deployment during TAVR - just like what we have been doing with PCI for decades!! Would this change your practice? https://t.co/pMsm5S1VUb
@9NewsSyd Congratulations to Prof Martin Ng, Michael Wilson and the rest of the wonderful team at Macquarie Hospital! Much deserved recognition of high quality patient care @DrShanthosh